ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
599 |
207K |
8 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
599
|
207K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.1K |
1.9M |
4 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
4.1K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.1K |
1.9M |
1 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
4.1K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
BIO International Convention
|
|
JamesTas
|
52 |
19K |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
52
|
19K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
599 |
207K |
5 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
599
|
207K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.1K |
1.9M |
4 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
4.1K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.1K |
1.9M |
12 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
4.1K
|
1.9M
|
12
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.1K |
1.9M |
4 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
4.1K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Charlie and the once in a lifetime post!
|
|
JamesTas
|
52 |
17K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
52
|
17K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Application for quotation of securities - PAR
|
|
JamesTas
|
14 |
4.4K |
3 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
14
|
4.4K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Charlie and the once in a lifetime post!
|
|
JamesTas
|
52 |
17K |
3 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
52
|
17K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.1K |
1.9M |
3 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
4.1K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
lowest ever
|
|
JamesTas
|
5 |
2.9K |
12 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
5
|
2.9K
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JamesTas
|
21K |
7.3M |
3 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
21K
|
7.3M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
JamesTas
|
104 |
31K |
9 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
31K
|
9
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
49K |
0 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
117
|
49K
|
0
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
49K |
6 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
117
|
49K
|
6
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
49K |
0 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
117
|
49K
|
0
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
49K |
2 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
117
|
49K
|
2
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
49K |
1 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
117
|
49K
|
1
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
49K |
4 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
117
|
49K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.8M |
8 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.8M |
6 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
JamesTas
|
236 |
93K |
7 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
236
|
93K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
599 |
207K |
6 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
599
|
207K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
599 |
207K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
599
|
207K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
JamesTas
|
670 |
255K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
670
|
255K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
JamesTas
|
46 |
16K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
16K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
JamesTas
|
46 |
16K |
8 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
16K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
599 |
207K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
599
|
207K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
599 |
207K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
599
|
207K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
599 |
207K |
20 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
599
|
207K
|
20
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
599 |
207K |
24 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
599
|
207K
|
24
|
|
ASX - By Stock
|
PAR |
Re:
Resolution of lumbar bone marrow oedema
|
|
JamesTas
|
76 |
35K |
16 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
76
|
35K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.8M |
11 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.8M |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Final Director's Interest Notice
|
|
JamesTas
|
19 |
5.9K |
5 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
19
|
5.9K
|
5
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Half Yearly Report and Accounts
|
|
JamesTas
|
24 |
5.8K |
2 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
24
|
5.8K
|
2
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Half Yearly Report and Accounts
|
|
JamesTas
|
24 |
5.8K |
10 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
24
|
5.8K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Half Yearly Report and Accounts
|
|
JamesTas
|
37 |
13K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
37
|
13K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
236 |
79K |
4 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
236
|
79K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
236 |
79K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
236
|
79K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
236 |
79K |
13 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
236
|
79K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
JamesTas
|
974 |
323K |
12 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
974
|
323K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
JamesTas
|
95 |
28K |
5 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
95
|
28K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
AGM Meeting
|
|
JamesTas
|
92 |
33K |
27 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
92
|
33K
|
27
|
|
ASX - By Stock
|
PAR |
Re:
If the claim is....then why ?
|
|
JamesTas
|
26 |
6.2K |
6 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
26
|
6.2K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2023 AGM Chairman Address
|
|
JamesTas
|
18 |
5.8K |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
18
|
5.8K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2023 AGM Chairman Address
|
|
JamesTas
|
18 |
5.8K |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
18
|
5.8K
|
2
|
|
ASX - By Stock
|
FRX |
FRX Shop front
|
|
JamesTas
|
1 |
581 |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
1
|
581
|
2
|
|